Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
Sponsor: Kenai Therapeutics
Summary
This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.
Official title: A Phase 1b/2a Study Assessing the Safety and Efficacy of Intraputamenal Dopaminergic Stem Cell Transplants in Patients With Idiopathic Parkinson's Disease
Key Details
Gender
All
Age Range
45 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2025-07-17
Completion Date
2031-06
Last Updated
2026-01-23
Healthy Volunteers
No
Interventions
RNDP-001
Stem cells
Syringe Front-Loading Device
Delivers the stem cells
Locations (3)
University of Arizona
Tucson, Arizona, United States
Keck Medical Center of University of Southern California
Los Angeles, California, United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States